# A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)

> **NCT05630833** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 380 (actual)

## Conditions studied

- Urinary Tract Infections

## Interventions

- **DRUG:** Gepotidacin
- **DRUG:** Nitrofurantoin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05630833
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-11
- **Primary completion:** 2024-02-02
- **Final completion:** 2024-02-02
- **Target enrollment:** 380 (ACTUAL)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05630833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05630833, "A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05630833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*